Skip to main content

Table 1 Baseline characteristics (n = 208) and assessments in survivors at 7 years (n = 111)

From: No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study

 Baseline7-year follow-up
Male (%)
Mean age, years (SD)
Less than 9 years of education (%)
105 (51)
72.0 (12.2)
50 (24)
46 (41)
75.2 (11.2)
Stroke subtype (%)
 Cerebral infarction
 TIA
 Cerebral hemorrhage
164 (79)
28 (14)
16 (7)
 
Risk factors (%)
 Hypertension*
 Hyperlipidemia
 Diabetes
 Cigarette smoking (present)
 Coronary heart disease
 Atrial fibrillation
 Daily alcohol use
BMI > 25
123 (59)
117 (56)
23 (11)
18 (18)
45 (22)
65 (31)
20 (24)
119 (57)
 
TOAST classification (%)
 Large-vessel disease
 Cardio-embolic disease
 Small-vessel disease
 Stroke of undetermined etiology
21 (10)
60 (29)
64 (31)
63 (30)
 
Assessments. Mean (SD) (n)
IQCODE
MMSE
NIHSS
BI
mRS
 TMT-A
 TMT-B
 10-Word test immediate recall
 10-Word test, delayed recall
3.1 (0.2) (n = 208) 
26.0 (4.5) (n = 195)
2.44 (4.6) (n = 208)
17.5 (5.1) (n = 208)
1.5 (1.4) (n = 208)
73.7 (66.7) (n = 177)
152.8 (89.8) (n = 152)
17.9 (2.9) (n = 170)
4.3 (2.5) (n = 184)
25.8 (5.9) (n = 109)
1.02 (2.3) (109)
18.7 (3.7) (109)
1.4 (1.3) (109)
55.7 (39.6) (n = 101)
126.4 (67.7) (n = 82)
22.5 (8) (n = 106)
4.7 (3) (n = 105)
  1. TIA = Transistent Ischemic Attack; Hyperlipidemia = total cholesterol > 5 mmol/L or LDL > 3 mmol/L; LDL = Low Density Lipoprotein; Diabetes = an established diagnosis or Haemoglobin A1C (HbA1c) ≥7.0; Coronary Heart Disease = previous myocardial infarction or present angina pectoris; BMI=Body mass index; TOAST = the trial of org 10,172 in acute stroke treatment classification; NIHSS=National Institute of Health Stroke Scale; BI=Barthel Activities of Daily Living Index; mRS = modified Rankin scale; IQCODE = the informant questionnaire on cognitive decline in the elderly. MMSE = Mini Mental State Examination; SD = standard deviation.* Hypertension = use of BP lowering drugs at baseline